Search
4D Molecular Therapeutics Inc
FDMTAdd to Watchlist
9.660USD
+0.240+2.55%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
504.94MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-06-18 The current financial score of 4D Molecular Therapeutics Inc is 7.21, ranking 140 out of 389 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 3.05M, representing a year-over-year increase of 21664.29%, while its net profit experienced a year-over-year increase of 43.33%.
Financials
7.31
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.07
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
3.11
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.58
Free cash flow
Relevant data have not been disclosed by the company yet.
